Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors

被引：0
|
作者：
Thomas Kuhnt
Axel Becker
Marc Bloching
Johannes Schubert
Gunther Klautke
Rainer Fietkau
Juergen Dunst
机构：
[1] Clinic for Radiotherapy,Clinic for Oral, Maxillo
[2] Staedt. Krankenhaus Dessau, and Plastic Facial Surgery
[3] Clinic for Head and Neck Surgery Martin-Luther-University Halle-Wittenberg,Clinic for Radiotherapy
[4] Martin-Luther-University Halle-Wittenberg,Clinic for Radiotherapy
[5] Clinic for Radiotherapy University Rostock,undefined
[6] University Luebeck,undefined
[7] Martin-Luther-University Halle-Wittenberg,undefined
来源：
Medical Oncology | 2006年 / 23卷
关键词：
Paclitaxel; Clin Oncol; Neck Cancer; Lymph Edema; Radiat Oncol Biol Phys;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Simultaneous radiochemotherapy (RCT) is the treatment of choice for locally advanced head and neck cancers. In order to evaluate the toxicity and the survival rates, we investigated the use of a very aggressive combination protocol that included cisplatinum and paclitaxel combined with hyperfractionated-accelerated radiotherapy. The final results of the phase II study are listed below.
引用
收藏
页码：325 / 333
页数：8
相关论文
共 50 条
  • [1] Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors
    Kuhnt, Thomas
    Becker, Axel
    Bloching, Marc
    Schubert, Johannes
    Klautke, Gunther
    Fietkau, Rainer
    Dunst, Juergen
    [J]. MEDICAL ONCOLOGY, 2006, 23 (03) : 325 - 333
  • [2] Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors -: Results of a phase I-II trial
    Kuhnt, T
    Becker, A
    Pigorsch, S
    Pelz, T
    Bloching, M
    Passmann, M
    Lotterer, E
    Hänsgen, G
    Dunst, J
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (10) : 673 - 681
  • [3] Assessment of the quality of life after hyperfractionated-accelerated simultaneous radiochemotherapy in locally advanced head-neck squamous cell carcinomas
    Roeper, B.
    Weipert, L.
    Papachristofilou, A.
    Riedmiller, S.
    Nuese, N.
    Hoelzel, D.
    Thamm, R.
    Zimmermann, F. B.
    Molls, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 12 - 13
  • [4] Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: Quality of life in a prospective phase I/II trial
    Ringash, Jolie
    Lockwood, Gina
    O'Sullivan, Brian
    Warde, Padraig
    Bayley, Andrew
    Cummings, Bernard
    Kim, John
    Sellmann, Susanna
    Waldron, John
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 87 (02) : 181 - 187
  • [5] Hyperfractionated accelerated radiotherapy in locally advanced head and neck cancers
    Yoney, Adnan
    Akboru, Halil
    Kandemir, Ozge
    Unsal, Mustafa
    [J]. ONKOLOGIE, 2007, 30 (10): : 479 - 484
  • [6] Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
    Beckmann, GK
    Hoppe, F
    Pfreundner, L
    Flentje, MP
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (01): : 36 - 43
  • [7] Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity
    Hoeller, U
    Biertz, I
    Flinzberg, S
    Tribius, S
    Schmelzle, R
    Alberti, W
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (03) : 157 - 163
  • [8] Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck
    Kuhnt, T.
    Sandner, A.
    Wendt, T.
    Engenhart-Cabillic, R.
    Lammering, G.
    Flentje, M.
    Grabenbauer, G.
    Schreiber, A.
    Pirnasch, A.
    Dunst, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (11) : 2284 - 2289
  • [9] Simultaneous hyperfractionated-accelerated radiotherapy (HART) in combination with cisplatin (CIS) and cetuximab (CET) in locally advanced squamous epithelial carcinoma of the head neck area: final results of the phase-1-study
    Kuhnt, T.
    Sandner, A.
    Wendt, T.
    Engenhart-Cabillic, R.
    Lammering, G.
    Flentje, M.
    Grabenbauer, G.
    Schreiber, A.
    Pirnasch, A.
    Baumann, M.
    Dunst, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 23 - 23
  • [10] SIMULTANEOUS COMBINED RADIOCHEMOTHERAPY IN HEAD AND NECK TUMORS USING CARBOPLATINUM AND HYPERFRACTIONATED ACCELERATED IRRADIATION
    KEHRL, W
    BROCKMANN, WP
    ZSCHABER, R
    HARTWEIN, J
    [J]. LARYNGO-RHINO-OTOLOGIE, 1992, 71 (07) : 370 - 374
12345